First study to utilize CGM data with FDA-cleared, cloud-based titration software suggests significantly improved outcomes for patients while optimizing clinical resources This past summer, Glytec published the first proof-of-concept study that combines FDA-cleared remote insulin titration software and data from continuous glucose monitoring (CGM) systems. Results of the study, presented at the American Diabetes Association’s...
Agency and industry must evaluate cumulative health effects of classes of related food chemicals. Today, a group of health, environmental, and consumer organizations challenged the Food and Drug Administration’s (FDA) practice of not accounting for the cumulative health effect of chemicals in the diet when allowing new chemicals in food. Over 60 years ago, Congress passed a law requiring that FDA and industry do just that. Unfortunately, an Environmental Defense Fund (EDF) investigation of nearly 900 safety determinations found that only one considered the requirement in a meaningful way....
Due to the “fractured” process of treating osteoporosis, Australian researchers and software developers teamed up to create a tool that uses artificial intelligence to read X-rays. The new program —XRAIT — has significantly improved fracture detection and could change the future of osteoporosis treatment. Christopher White, MBBS, PhD, FRACP, an endocrinologist at Prince of Wales...
A clinical trial investigating a possible novel treatment of early-onset type 1 diabetes last month met the primary endpoint assessing the safety and tolerability of a new class of microbe-based therapeutic agents. Precigen ActoBio is evaluating this therapy — AG019 ActoBiotics — as a monotherapy and in combination with teplizumab. AG019 is formulated as an...
In a preview of his on-demand CEU 2020 session, “When It’s Not Your Thyroid,” James V. Hennessey, MD, presents a series of questions about thyroid patients, what their symptoms mean, as well as what they don’t mean. Sir Arthur Conan Doyle once said, “It is a capital mistake to theorize before one has data.” This...
As heart disease continues to kill more people than any other ailment annually, more endocrine research is linking endocrine disruptors to cardiovascular health. Patients can reduce their own exposure to these compounds. Cardiovascular disease (CVD) is the leading cause of mortality in the U.S., responsible for a quarter of all deaths, with someone succumbing to...
As the COVID-19 pandemic became more serious, the Endocrine Society joined a coalition of bone health organizations that united to issue new osteoporosis treatment guidelines. Aside from addressing the challenges social distancing has placed on treating these patients, the coalition has also focused on the administration of osteoporosis medications including denosumab, teriparatide, abaloparatide, romosozumab, and...
Two clinical trials have shown positive topline data that add to the growing body of evidence supporting the efficacy and safety of teprotumumab-trbw for the treatment of Thyroid Eye Disease (TED). Horizon Therapeutics is marketing the drug as TEPEZZA, the first medicine approved by the U.S. Food and Drug Administration (FDA) for the treatment of...
As much as we know today about the endocrine system and the effects it has on the body, there remains so much that we do not know. Discoveries are made every day, and our understanding of the endocrine system is always growing and changing. Serving patients to the best of an endocrinologist’s abilities means being aware of all the latest developments in endocrine research. This includes the newest and most complete information concerning such endocrinology research topics as new treatments and new methods for disease prevention. Identifying symptoms and making the connections between those symptoms and endocrine disease can lead to greater understanding and ultimately better treatment for patients. More advanced prevention techniques can help patients stave off disease before it can impact their lives. Having the most current information can make a tremendous difference in the quality of life for your patients.
This section features some of the most current and forward-looking articles concerning the latest research in endocrinology. Written by and for endocrinologists, these articles are provided to keep you up to date with the most relevant developments in the field of endocrinology. You can access the information you need about new technology, new treatments and general information to help you serve your patients with better overall care. Our understanding of the endocrine system is always evolving. With Endocrine News, you can ensure that your knowledge of the field won’t be left behind. What’s more, your patients will always have access to the most advanced information out there.
Due to the “fractured” process of treating osteoporosis, Australian researchers and software developers teamed up to create a tool that uses artificial intelligence to read X-rays. The new program —XRAIT — has significantly improved fracture detection and could change the future of osteoporosis treatment. Christopher White, MBBS, PhD, FRACP, an endocrinologist at Prince of Wales...
In a preview of his on-demand CEU 2020 session, “When It’s Not Your Thyroid,” James V. Hennessey, MD, presents a series of questions about thyroid patients, what their symptoms mean, as well as what they don’t mean. Sir Arthur Conan Doyle once said, “It is a capital mistake to theorize before one has data.” This...
As heart disease continues to kill more people than any other ailment annually, more endocrine research is linking endocrine disruptors to cardiovascular health. Patients can reduce their own exposure to these compounds. Cardiovascular disease (CVD) is the leading cause of mortality in the U.S., responsible for a quarter of all deaths, with someone succumbing to...
